Individualizing Neo/Adjuvant Treatment in Early Breast Cancer Care: Education, Tools, and Resources for Patients and Providers

Review the latest evidence-based strategies on individualized early breast cancer treatment with expert commentaries online modules downloadable slidesets and an Interactive Decision Support Tool that provides personalized management recommendations for treatment selection in early breast cancer.

Resources for your patients:&nbsp https://www.smartpatients.com/resources/cco-ebc

Share

Program Content

Activities

EBC Changing Landscape
Adapting to the Changing Treatment Landscape in Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Expires: February 21, 2023

View Activity
HR and TNBC EBC Tool
An Interactive Treatment Decision Tool for HER2-Negative Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 07, 2022

Expires: September 06, 2023

View Activity

Activities

Biomarkers in HER2-Negative EBC
Overview of Risk Assessment and Biomarker Testing to Inform Treatment in HER2-Negative Early Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2022

Expires: April 05, 2023

View Activity
Adj Abemaciclib HR+/HER2- EBC
Risk Assessment and Ki-67 Testing in HR-Positive/HER2-Negative EBC for Adjuvant Abemaciclib
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2022

Expires: May 11, 2023

View Activity
Adjuvant Olaparib in HER2- EBC
Germline BRCA Testing and Targeting With Adjuvant Olaparib in HER2- EBC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2022

Expires: May 16, 2023

View Activity
ICI in Early TNBC
Immune Checkpoint Inhibition in Early-Stage TNBC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2022

Expires: September 14, 2023

View Activity
Key Trials in HR+/HER2- EBC
Key Ongoing Clinical Trials in HR-Positive/HER2-Negative Early-Stage Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

View Activity

Activities

Biomarkers in HER2-Negative EBC
Overview of Risk Assessment and Biomarker Testing to Inform Treatment in HER2-Negative Early Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2022

Expires: April 05, 2023

View Activity
Adj Abemaciclib HR+/HER2- EBC
Risk Assessment and Ki-67 Testing in HR-Positive/HER2-Negative EBC for Adjuvant Abemaciclib
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2022

Expires: May 11, 2023

View Activity
Adjuvant Olaparib HER2- EBC
Germline BRCA Testing and Targeting With Adjuvant Olaparib in HER2- EBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2022

Expires: May 16, 2023

View Activity
ICI in Early TNBC
Immune Checkpoint Inhibition in Early-Stage TNBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2022

Expires: September 14, 2023

View Activity
Key Trials in HR+/HER2- EBC
Key Ongoing Clinical Trials in HR-Positive/HER2-Negative Early-Stage Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

View Activity

Activities

(Neo) Adjuvant Tx HER2-Negative EBC
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: September 06, 2022

Expires: September 05, 2023

View Activity

Faculty

cover img faculity

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

cover img faculity

Yara Abdou, MD

Assistant Professor
Division of Medical Oncology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Kevin Kalinsky, MD, MS

Professor of Medicine
Director, Glenn Family Breast Center
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tiffany A. Traina, MD

Assistant Attending
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Department of Medicine
Weill Medical College of Cornell University
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner